Taxanes in the management of gynecologic malignancies. - Wikidata - awgldk - TriplyDB

Taxanes in the management of gynecologic malignancies.

Taxanes in the management of gynecologic malignancies.

http://www.wikidata.org/entity/Q37086007

about

Role of Akt signaling in resistance to DNA-targeted therapy Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: a tangible union against chemoresistant cancer Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer.

P2860

Q28066950-DC22F23B-056C-4FCC-8607-E2D04FD40BB7 Q34001266-B8CC2C6B-6F86-496A-BABF-F2645C03A88A Q37209539-37C79FFB-282A-4251-AADE-E1258EB320D7

P2860

Taxanes in the management of gynecologic malignancies.

http://www.wikidata.org/entity/Q37086007

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Taxanes in the management of gynecologic malignancies.

@en

Taxanes in the management of gynecologic malignancies.

@nl

type

label

Taxanes in the management of gynecologic malignancies.

@en

Taxanes in the management of gynecologic malignancies.

@nl

prefLabel

Taxanes in the management of gynecologic malignancies.

@en

Taxanes in the management of gynecologic malignancies.

@nl

P1433

Q37086007-6B3C18D5-0650-4EB9-B203-77533B0B0B26

P1476

Q37086007-1FC490B8-D8B9-486F-A815-C4333DA003D3

P2093

Q37086007-03AB46B7-C0E1-433A-B4E9-D87CBA23FDC1

P2860

Q37086007-0522155C-17C8-41DD-B52B-07456E87B0FC

Q37086007-0A0A5FC6-F6AF-4193-BDA5-57677EDF3EA0

Q37086007-0FA00B29-C8DD-42AE-85CD-C25FCC169E94

Q37086007-25E95275-A57B-41DE-BE9F-E27368869C70

Q37086007-2767CA71-ED26-48B3-9C0C-1C3272FEA85C

Q37086007-2895826D-7D19-4039-B909-8542E4EFDBF2

Q37086007-32577548-43DB-4B0C-94DA-70D0547727CD

Q37086007-33E9DE79-382C-469D-9AB1-6A4E53752C79

Q37086007-3FB3C039-E5D1-4443-A8B0-88B54C9A3C2D

Q37086007-4024B5C0-67B7-49E6-BF22-9EC9D0A8FF68

P304

Q37086007-B6519E27-D5FB-469B-99C6-670779CF9203

P31

Q37086007-E3DB1757-751B-4771-8C7D-6B3EAD87D79E

P356

Q37086007-2C9B5525-436F-410F-A0AA-F581EDCA1FDB

P433

Q37086007-E5819B6A-AF2F-465D-901F-520A39C84181

P478

Q37086007-03F22207-DB20-42FA-A6D1-D6658C516373

P577

Q37086007-4695FD23-B910-4B48-A731-1C0E0904AFBD

P698

Q37086007-B3E7B95B-5811-4954-A3AA-EBC5A31499EF

P356

14737140.8.2.219

P1433

Expert Review of Anticancer Therapy

P1476

Taxanes in the management of gynecologic malignancies.

@en

P2093

Maurie Markman

http://www.w3.org/2001/XMLSchema#string

P2860

Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.

Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study.

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

The activity of taxanes in the treatment of sex cord-stromal ovarian tumors.

The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors.

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study.

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial.

Granulosa cell tumor of the ovary.

Chronic administration of single-agent paclitaxel in gynecologic malignancies.

P304

219-226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.8.2.219

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18279063

http://www.w3.org/2001/XMLSchema#string